CD34 and Stroke: Using intra‐arterial administration of 100 million autologous, immunoselected CD34+ stem/progenitor cells in five stroke patients within 7 days after severe anterior ischemic stroke (NIHSS score ≥ 8) manifested improvements in NIHSS score and in the modified Rankin scale.78